Objectives Extra-criteria manifestations of antiphospholipid syndrome (APS) might impact on
prognosis and morbidity of the disease. In this study, we aimed to evaluate a population of …

Antiphospholipid antibodies (aPL) occur in a variety of autoimmune, malignant, and
infectious diseases, with or without the thrombotic or obstetric sequelae that characterize the …

Objective. To systematically review and establish the prevalence of antibody positivity in
assays not currently included in the APS classification criteria to detect antibodies directed …

Preliminary classification criteria for the antiphospholipid syndrome (APS) were formulated
during a post-conference workshop held October 10, 1998 in Sapporo, Japan, following the …

Objective To estimate the annual incidence and prevalence of and frequency of mortality
associated with antiphospholipid syndrome (APS). Methods An inception cohort of patients …

Antiphospholipid syndrome (APS) is a heterogeneous entity with a wide variation in clinical
course and laboratory profile. It is accepted that the presence of antiphospholipid antibodies …

Objective This study was performed to prospectively and independently validate the Global
Antiphospholipid Syndrome Score (GAPSS), a system derived from the combination of …

Several antiphospholipid antibody (aPL) profiles (“triple” and lupus anticoagulant [LA]
positivity) are associated with a higher risk for clinical manifestations of antiphospholipid …

Abstract Purpose of Review APS ACTION is an international research network created to
design and conduct large-scale, multicenter research in persistently antiphospholipid …

The antiphospholipid syndrome (APS) is an autoimmune condition associated with
thrombosis (venous or arterial) and adverse pregnancy outcomes. Investigation of APS …